BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 18, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 30, 2006
View Archived Issues
Dasatinib effective in imatinib-resistant leukemia
Read More
In vitro and in vivo characteristics of ofatumumab described
Read More
Oncolytic agents benefit from PPARgamma receptor-dependent and -independent dual mechanism
Read More
LC16m8 protects monkeys from monkeypox
Read More
Pooled data suggest heptavalent DTPw-HBV/Hib-MenAC vaccine is safe
Read More
Sosei and Mundipharma sign agreement for AD-923
Read More
ELI-154 completes second pilot phase I study
Read More
Phase II trial planned for atiprimod in advanced carcinoid cancer
Read More
Updated clinical data on tocilizumab as a treatment for arthritic disease
Read More
Phase II data report lack of efficacy for apratastat in RA
Read More
No safety concerns in phase II BPH study of NX-1207
Read More
Gantacurium chloride completes phase II study in endotracheal intubation
Read More
NVA-237 successfully completes phase IIb study in COPD
Read More
Mirtazapine results in obstructive sleep apnea do not warrant further studies
Read More
ASF-1075 studied for hand dermatitis in new study
Read More
XL-880 advances into phase II for papillary renal cell carcinoma
Read More
CMX-001 for treatment of smallpox infection cleared to begin phase I
Read More
Panzem awarded orphan drug designation for glioblastoma multiforme
Read More
NIAID to conduct antimicrobial evaluation of Viprovex
Read More
CoTherix inlicenses rights to oral and inhaled formulations of fasudil
Read More
Daytrana now available
Read More
VR-004 improves erectile performance with rapid onset of action
Read More
Revlimid approved for use in multiple myeloma
Read More
Novel antiinfective agents reported in recent patent literature
Read More
First launch for Acomplia
Read More
New agents for treating endocrine-related disorders patented
Read More
Melanocortin receptor agonist shows therapeutic potential in experimental arthritis
Read More
Phase II trial results of belimumab in systemic lupus erythematosus
Read More